LEO Pharma Investigational Site

Chicago, Illinois 60611

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials